Updated:
Namarel Ventures
Namarel Ventures is an active healthcare investor providing financing and sector expertise to innovative early-stage companies. It looks for companies...
Namarel Ventures
Namarel Ventures is an active healthcare investor providing financing and sector expertise to innovative early-stage companies. It looks for companies developing medical devices, diagnostics or digital health solutions with the ambition to transform the global healthcare market. It supports entrepreneurs taking their first steps in business creation to accelerate their growth, focusing on companies with global impact that improve people's quality of life.
General information
Firm type
Venture Capital
Year founded
2018
Location
Region
Europe
Country
Spain
City
Barcelona
Corporate office
Barcelona, Spain
Sector focus
Frequently asked questions
What is Namarel Ventures' geographic investment focus?
The firm invests primarily in Southern Europe, with its headquarters in Barcelona anchoring a focus on the Spanish startup ecosystem. Neighboring European markets with emerging technology clusters also fall within the firm's geographic scope. Barcelona's growth as a tech hub, driven by events like Mobile World Congress and a rising density of engineering talent, provides the firm's immediate sourcing environment.
Does Namarel Ventures lead rounds or participate as a co-investor?
Specific information regarding Namarel Ventures' typical check size, ownership targets, or lead versus follow posture has not been publicly disclosed. Early-stage firms in Southern Europe often act as lead investors in pre-seed and seed rounds given the limited local capital pool, but no explicit confirmation exists for Namarel Ventures' approach.
Are there any known portfolio companies or exits associated with Namarel Ventures?
No specific portfolio company names, co-investors, or exit events have been publicly documented for Namarel Ventures. The firm maintains a low public profile, which is not uncommon for early-stage investors operating outside major venture reporting corridors and without a regulatory obligation to disclose positions.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on venture capital firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: